(Q36109106)

12 August 2017

Circulating dopamine and C-peptide levels in fasting nondiabetic hypertensive patients: the Graz Endocrine Causes of Hypertension study (English)

1 reference

12 August 2017

5

Winfried März

1 reference

12 August 2017

4

Burkert Pieske

1 reference

12 August 2017

9

Stefan Pilz

1 reference

12 August 2017

Andreas Tomaschitz

1

1 reference

12 August 2017

Eberhard Ritz

2

1 reference

12 August 2017

Katharina Kienreich

3

1 reference

12 August 2017

Bernhard O Boehm

6

1 reference

12 August 2017

Christiane Drechsler

7

1 reference

12 August 2017

Andreas Meinitzer

8

1 reference

12 August 2017

language of work or name

English

0 references

publication date

14 June 2012

1 reference

12 August 2017

1 reference

12 August 2017

35

1 reference

12 August 2017

8

1 reference

12 August 2017

1771-1773

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

12 August 2017

start time

28 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402263

Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402263

Diagnosis and classification of diabetes mellitus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402263

Neuronal source of plasma dopamine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402263

Metabolic consequences of atypical antipsychotic drugs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402263

Epinephrine: selective inhibition of the acute insulin response to glucose

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402263

Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402263

Disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402263

Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402263

Bromocriptine: a novel approach to the treatment of type 2 diabetes.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402263

Lack of evidence for bromocriptine effect on glucose tolerance, insulin resistance, and body fat stores in obese type 2 diabetic patients.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402263

Dopaminergic regulation of glucose-induced insulin secretion through dopamine D2 receptors in the pancreatic islets in vitro

23 September 2018

1 reference

12 December 2020

Dopamine-induced antihypertensive effects and plasma insulin rise are blocked by metoclopramide in labetalol-treated patients

1 reference

12 December 2020

Inhibition of Insulin Secretion by Serotonin and Dopamine: Species Variation1

1 reference

12 December 2020

Thermogenic and metabolic effects of dopamine in healthy men

1 reference

12 December 2020

Identifiers

DOI

10.2337/DC11-2384

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22699284

1 reference